Muddasani Suraj, Heron Courtney E, Fleischer Alan B, Feldman Steven R
J Drugs Dermatol. 2020 Dec 1;19(12):1226-1230. doi: 10.36849/JDD.2020.5542.
Poor patient adherence to medications is common in dermatology and can result in negative health outcomes. A short interval until the first return office visit after starting a medication can increase adherence.
We conducted a retrospective cross-sectional study by using the National Ambulatory Medical Care Survey from 2014 to 2016 to determine the length of time until the scheduled return visit.
Our study examined 10.9 (95% confidence interval 9.43, 12.5) million estimated visits in the NAMCS. Patients with acne, atopic dermatitis, and psoriasis prescribed at least one new medication had dispositions to return at two months or greater or to return as needed at 73.5% (38.8, 100), 49.1% (12.6, 92.0), and 55.0 % (14.0, 100) of visits, respectively.
The time for a first return visit is frequently more than two months after a new medication is prescribed. Incorporating an earlier visit when prescribing a medication may be a means to improve adherence. J Drugs Dermatol. 2020;19(12): doi:10.36849/JDD.2020.5542.
患者对药物治疗的依从性差在皮肤科很常见,并且可能导致不良健康后果。开始用药后至首次复诊的间隔时间较短可提高依从性。
我们使用2014年至2016年的国家门诊医疗调查进行了一项回顾性横断面研究,以确定至预定复诊的时间长度。
我们的研究在国家门诊医疗调查中检查了1090万次(95%置信区间943万次,1250万次)估计就诊。痤疮、特应性皮炎和银屑病患者在开具至少一种新药后,分别有73.5%(38.8%,100%)、49.1%(12.6%,92.0%)和55.0%(14.0%,100%)的就诊倾向于在两个月或更长时间后复诊或按需复诊。
开具新药后首次复诊的时间通常超过两个月。在开药时安排更早的复诊可能是提高依从性的一种方法。《药物与皮肤病学杂志》。2020年;19(第12期):doi:10.36849/JDD.2020.5542 。